These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 30134537)

  • 21. Drug Nanocrystals: A Comprehensive Review with Current Regulatory Guidelines.
    Dhaval M; Makwana J; Sakariya E; Dudhat K
    Curr Drug Deliv; 2020; 17(6):470-482. PubMed ID: 32394834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probing adsorption of DSPE-PEG2000 and DSPE-PEG5000 to the surface of felodipine and griseofulvin nanocrystals.
    Rydberg HA; Yanez Arteta M; Berg S; Lindfors L; Sigfridsson K
    Int J Pharm; 2016 Aug; 510(1):232-9. PubMed ID: 27329674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stabilizing Agents for Drug Nanocrystals: Effect on Bioavailability.
    Tuomela A; Hirvonen J; Peltonen L
    Pharmaceutics; 2016 May; 8(2):. PubMed ID: 27213435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development Considerations for Nanocrystal Drug Products.
    Chen ML; John M; Lee SL; Tyner KM
    AAPS J; 2017 May; 19(3):642-651. PubMed ID: 28281194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug nanocrystals: In vivo performances.
    Gao L; Liu G; Ma J; Wang X; Zhou L; Li X
    J Control Release; 2012 Jun; 160(3):418-30. PubMed ID: 22465393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combinative Particle Size Reduction Technologies for the Production of Drug Nanocrystals.
    Salazar J; Müller RH; Möschwitzer JP
    J Pharm (Cairo); 2014; 2014():265754. PubMed ID: 26556191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method.
    Shi-Ying J; Jin H; Shi-Xiao J; Qing-Yuan L; Jin-Xia B; Chen HG; Rui-Sheng L; Wei W; Hai-Long Y
    Chin J Nat Med; 2014 Jan; 12(1):71-80. PubMed ID: 24484600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in nanocrystal-based technologies applied for ocular drug delivery.
    Geng F; Fan X; Liu Y; Lu W; Wei G
    Expert Opin Drug Deliv; 2024 Feb; 21(2):211-227. PubMed ID: 38271023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug Nanocrystals for Active Tumor-Targeted Drug Delivery.
    Lu L; Xu Q; Wang J; Wu S; Luo Z; Lu W
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanotechnology Based Approaches for Enhancing Oral Bioavailability of Poorly Water Soluble Antihypertensive Drugs.
    Sharma M; Sharma R; Jain DK
    Scientifica (Cairo); 2016; 2016():8525679. PubMed ID: 27239378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticles in the pharmaceutical industry and the use of supercritical fluid technologies for nanoparticle production.
    Sheth P; Sandhu H; Singhal D; Malick W; Shah N; Kislalioglu MS
    Curr Drug Deliv; 2012 May; 9(3):269-84. PubMed ID: 22283656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced Dissolution Rate of Tadalafil Nanoparticles Prepared by Sonoprecipitation Technique: Optimization and Physicochemical Investigation.
    Teymouri Rad R; Mortazavi SA; Vatanara A; Dadashzadeh S
    Iran J Pharm Res; 2017; 16(4):1335-1348. PubMed ID: 29721025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vitro and In Vivo Evaluation of Olmesartan Medoxomil Microcrysta ls and Nanocrystals: Preparation, Characterization, and Pharmacokinet ic Comparison in Beagle Dogs.
    Chai R; Gao H; Ma Z; Guo M; Fu Q; Liu H; He Z
    Curr Drug Deliv; 2019; 16(6):500-510. PubMed ID: 31244438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of effective stabilizers in improving oral bioavailability of naringenin nanocrystals: Maintenance of supersaturation generated upon dissolution by inhibition of drug dimerization.
    Zhang G; Guan H; Li J; Li M; Sui X; Tian B; Dong H; Liu B; He Z; Li N; Zhao M; Fu Q
    Asian J Pharm Sci; 2022 Aug; 17(5):741-750. PubMed ID: 36382308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Broad overview of engineering of functional nanosystems for skin delivery.
    Mota AH; Rijo P; Molpeceres J; Reis CP
    Int J Pharm; 2017 Nov; 532(2):710-728. PubMed ID: 28764984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrohydrodynamic atomization and spray-drying for the production of pure drug nanocrystals and co-crystals.
    Sverdlov Arzi R; Sosnik A
    Adv Drug Deliv Rev; 2018 Jun; 131():79-100. PubMed ID: 30031740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced oral bioavailability of glycyrrhetinic acid via nanocrystal formulation.
    Lei Y; Kong Y; Sui H; Feng J; Zhu R; Wang W
    Drug Deliv Transl Res; 2016 Oct; 6(5):519-25. PubMed ID: 27206446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and Evaluation of Novel Solid Self-Nanodispersion Delivery System for Andrographolide.
    Xu J; Ma Y; Xie Y; Chen Y; Liu Y; Yue P; Yang M
    AAPS PharmSciTech; 2017 Jul; 18(5):1572-1584. PubMed ID: 27620195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug nanocrystals: four basic prerequisites for formulation development and scale-up.
    Srivalli KM; Mishra B
    Curr Drug Targets; 2015; 16(2):136-47. PubMed ID: 25410407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation.
    Chang D; Ma Y; Cao G; Wang J; Zhang X; Feng J; Wang W
    Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1018-1024. PubMed ID: 28749189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.